84 related articles for article (PubMed ID: 30397556)
1. Elucidation of Therapeutic Peptide Binding Partners from Isolated Mitochondria.
Mozayan A; Khaled A
Cureus; 2018 Jun; 10(6):e2898. PubMed ID: 30397556
[TBL] [Abstract][Full Text] [Related]
2. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
[TBL] [Abstract][Full Text] [Related]
3. Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.
Bassiouni R; Nemec KN; Iketani A; Flores O; Showalter A; Khaled AS; Vishnubhotla P; Sprung RW; Kaittanis C; Perez JM; Khaled AR
Clin Cancer Res; 2016 Sep; 22(17):4366-79. PubMed ID: 27012814
[TBL] [Abstract][Full Text] [Related]
4. Rational development of a cytotoxic peptide to trigger cell death.
Boohaker RJ; Zhang G; Lee MW; Nemec KN; Santra S; Perez JM; Khaled AR
Mol Pharm; 2012 Jul; 9(7):2080-93. PubMed ID: 22591113
[TBL] [Abstract][Full Text] [Related]
5. Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.
Carr AC; Khaled AS; Bassiouni R; Flores O; Nierenberg D; Bhatti H; Vishnubhotla P; Manuel JP; Santra S; Khaled AR
Oncotarget; 2017 Dec; 8(66):110273-110288. PubMed ID: 29299146
[TBL] [Abstract][Full Text] [Related]
6. [Hirsutine induces apoptosis of human breast cancer MDA-MB-231 cells through mitochondrial pathway].
Huang QW; Zhai NN; Huang T; Li DM
Sheng Li Xue Bao; 2018 Feb; 70(1):40-46. PubMed ID: 29492513
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
Moon D; McCormack D; McDonald D; McFadden D
J Surg Res; 2013 Apr; 180(2):208-15. PubMed ID: 22572619
[TBL] [Abstract][Full Text] [Related]
8. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
[TBL] [Abstract][Full Text] [Related]
9. Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma.
Cox A; Nierenberg D; Camargo O; Lee E; Khaled AS; Mazar J; Boohaker RJ; Westmoreland TJ; Khaled AR
Front Oncol; 2022; 12():975088. PubMed ID: 36185250
[TBL] [Abstract][Full Text] [Related]
10. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells.
Si L; Fu J; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 May; 685():108284. PubMed ID: 32014401
[TBL] [Abstract][Full Text] [Related]
11. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.
Huang MB; Wu JY; Lillard J; Bond VC
Oncotarget; 2019 Sep; 10(52):5419-5438. PubMed ID: 31534628
[No Abstract] [Full Text] [Related]
12. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment.
Salimi V; Shahsavari Z; Safizadeh B; Hosseini A; Khademian N; Tavakoli-Yaraki M
Lipids Health Dis; 2017 Nov; 16(1):208. PubMed ID: 29096636
[TBL] [Abstract][Full Text] [Related]
13. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
[TBL] [Abstract][Full Text] [Related]
15. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.
Ke K; Lou T
Oncol Lett; 2017 Nov; 14(5):5994-6000. PubMed ID: 29113237
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells.
Zafar A; Singh S; Satija YK; Saluja D; Naseem I
Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287
[TBL] [Abstract][Full Text] [Related]
18. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogens regulate the expression of genes involved in different biological processes in BRCA2 knocked down MCF-7, MDA-MB-231 and MCF-10a cell lines.
Bernard-Gallon DJ; Satih S; Chalabi N; Rabiau N; Bosviel R; Fontana L; Bignon YJ
Oncol Rep; 2010 Mar; 23(3):647-53. PubMed ID: 20127002
[TBL] [Abstract][Full Text] [Related]
20. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
